VITAL THERAPIES INC Chart calendar Vital Therapies Inc
e59a823cc6fd34e4313503fd4b55d288.399Qcv8T7fZx8PQwcGQUP_zb8EvHypDiVq7_cwqnKmc.6Y4INq4m35RFl71eMVYjfKmeqnmXpr2nYsmtAUjFZxDprwE3uUqImieGtQ~7d9c8639e15fca92ea8447853fd986e4
Upcoming events on Vital Therapies Inc
Past events on Vital Therapies Inc
| 08/05/2024 05:30 pm | Q1 2024 Earnings Call |
| 08/05/2024 04:00 pm | Q1 2024 Earnings Release |
| 18/04/2024 07:30 pm | Noble Capital Markets Emerging Growth Virtual Health Care Equity Conference |
| 15/04/2024 | Accelerating Bio-Innovation UK Conference |
| 09/04/2024 11:00 pm | R&D Day |
| 28/03/2024 03:30 pm | Society for Virology Meeting - Abstract Number: 73 |
| 25/03/2024 05:30 pm | Society for Virology Meeting - Abstract Number: 107 |
| 18/03/2024 09:30 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session II |
| 17/03/2024 10:30 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session I |
| 11/03/2024 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 | Clinical Trial Supply Europe Conference |
| 06/03/2024 | Temperature Controlled Logistics In Biopharmaceuticals Europe Conference |
| 04/03/2024 08:30 pm | Extraordinary Shareholders Meeting |
| 01/03/2024 04:30 pm | ACTRIMS Forum - Abstract Number: 6 |
| 29/02/2024 04:30 pm | ACTRIMS Forum - Abstract Number: 509 |
| 22/02/2024 06:30 pm | Q4 2023 Earnings Call |
| 22/02/2024 05:00 pm | Q4 2023 Earnings Release |
| 08/02/2024 | BioCapital Europe Conference |
| 01/02/2024 | Genotoxicity and Nitrosamine Conference |
| 08/01/2024 | JPMorgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -37,0 -36,5 -1.39% | -49,0 -48,3 -1.35% | -75,4 -89,4 15.63% | -86,5 -81,9 -5.69% | -99,2 -98,8 -0.46% | -91,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -91,0 -2.11% | -120 -83,8 -43.75% | -93,6 -94,7 1.14% | -96,2 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -90,8 -2.36% | -120 -91,1 -32.18% | -93,6 -95,4 1.87% | -99,1 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -2,81 -2,86 1.69% | -3,93 -3,89 -0.96% | -3,78 -2,90 -30.52% | -2,11 -2,14 1.52% | -1,00 |
| Announcement Date | 16/03/20 | 26/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,4 -21,7 1.31% | -20,6 -22,3 7.61% | -20,1 -19,9 -1.29% | -24,4 -19,7 -23.66% | -27,3 -20,9 -30.57% | -25,0 -22,3 -12.37% | -23,6 -24,0 1.97% | -23,4 -22,9 -2% | -23,9 -22,2 -7.67% | -22,3 | -22,3 | -22,5 | -22,0 | -23,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,8 -20,4 -1.86% | -21,9 -22,4 2.24% | -21,2 -20,0 -6.36% | -56,5 -19,8 -184.85% | -25,3 -21,0 -20.15% | -24,0 -22,3 -7.73% | -22,8 -23,8 4.4% | -21,6 -22,6 4.76% | -29,6 -22,1 -33.96% | -22,2 | -22,2 | -22,4 | -22,0 | -23,0 |
|
Net income Million USD | Released Forecast Spread | -20,8 -20,8 0.15% | -21,9 -22,2 1.13% | -21,2 -20,1 -5.34% | -56,5 -27,7 -104.24% | -25,3 -21,6 -16.86% | -24,0 -23,1 -3.86% | -22,8 -24,3 6.25% | -21,6 -23,4 7.66% | -29,6 -22,4 -32.03% | -22,6 | -23,0 | -23,6 | -22,0 | -23,0 |
|
EPS USD | Released Forecast Spread | -0,74 -0,79 5.73% | -0,72 -0,72 -0.28% | -0,69 -0,66 -4.81% | -1,62 -0,74 -117.74% | -0,58 -0,52 -12.08% | -0,54 -0,53 -2.86% | -0,51 -0,55 6.85% | -0,48 -0,51 6.34% | -0,30 -0,26 -15.38% | -0,23 | -0,23 | -0,24 | -0,22 | -0,19 |
| Announcement Date | 10/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 11/05/23 | 03/08/23 | 14/11/23 | 22/02/24 | 08/05/24 | - | - | - | - | - |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |